SYNTHESIS OF DEUTERIUM-LABELED SALICYLCARNOSINE

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

The effect of temperature on the effectiveness of the introduction of deuterium into a new biologically active compound salicylcarnosine (SC) has been studied. Deuterium gas and heavy water were used as a source of deuterium. The synthesis of labeled SC by the solid-phase method at 190°C leads to the production of [D]SC with a yield of 53%, and a deuterium content of about 4.8 atoms per molecule. During isotope exchange with deuterated water, it was shown that after pretreatment of the catalyst at room temperature with deuterium gas, isotope exchange between SC protons and deuterated water occurs more efficiently. [D]SC is formed with a yield of 46% and contains about 7.3 deuterium atoms per molecule. During the preparative synthesis of labeled SC according to this technique at 190°C, the yield of [D]SC was 6070%, with a deuterium content of about 6.2 atoms per molecule. A new technique for activating the inclusion of deuterium in peptides opens up additional opportunities for obtaining highly labelled drugs.

Негізгі сөздер

Авторлар туралы

V. Shevchenko

Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG)

Хат алмасуға жауапты Автор.
Email: nagaev@img.ras.ru
Russian, 123182, Moscow

I. Nagaev

Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG)

Email: kulikova@neurology.ru
Russian, 123182, Moscow

O. Kulikova

Research Center of Neurology (RCN)

Хат алмасуға жауапты Автор.
Email: kulikova@neurology.ru
Russian, 125367, Moscow

N. Myasoedov

Institute of Molecular Genetics of National Research Centre “Kurchatov Institute” (NRC “Kurchatov Institute” – IMG)

Email: kulikova@neurology.ru
Russian, 123182, Moscow

Әдебиет тізімі

  1. Ekinci D., Şentürk M., Küfrevioğlu O.I. // Expert Opin. Ther. Pat. 2011. V. 21. № 12. P. 1831–1841. https://doi.org/10.1517/13543776.2011.636354
  2. Berezhnoy D.S., Stvolinsky S.L., Lopachev A.V., Devyatov A.A., Lopacheva O.M., Kulikova O.I., Abaimov D.A., Fedorova T.N. // Amino Acids. 2019. V. 51. № 1. P. 139–150. https://doi.org/10.1007/s00726-018-2667-7
  3. Танашян М.М., Федорова Т.Н., Стволинский С.Л., Андреева Л.А., Нагаев И.Ю., Мигулин В.А., Шабалина А.А., Трубицына И.Е., Лопачев А.В., Куликова О.И., Абаимов Д.А. Патент РФ 2694061. 2019.
  4. Kulikova O.I., Stvolinsky S.L., Migulin V.A., Andre-eva L.A., Nagaev I.Yu., Lopacheva O.M., Kulichenko-va K.N., Lopachev A.V., Trubitsina I.E., Fedorova T.N. // DARU J. Pharm. Sci. 2020. V. 28. P. 119–130. https://doi.org/10.1007/s40199-019-00323-x
  5. Стволинский С.Л., Федорова Т.Н., Хуторова А.В., Лопачев А.В., Тимошина Ю.А., Куликова О.И., Танашян М.М. Патент РФ 2780112. 2022.
  6. Шевченко В.П., Нагаев И.Ю., Федорова Т.Н., Мясоедов Н.Ф. // Докл. Российской академии наук. Науки о жизни. 2023. Т. 508. С. 23–29. https://doi.org/10.31857/S2686738922700020
  7. Шевченко В.П., Нагаев И.Ю., Шапошников А.И., Шевченко К.В., Белимов А.А., Баташева С.Н., Гоголева Н.Е., Гоголев Ю.В., Мясоедов Н.Ф. // ДАН. 2018. Т. 483. № 3. С. 274–278. https://doi.org/10.31857/S086956520003247-4
  8. Шевченко В.П., Нагаев И.Ю., Лопачев А.В., Мясоедов Н.Ф. // Хим-фарм. журн. 2022. Т. 56. № 11. С. 48–52. https://doi.org/10.30906/0023-1134-2022-56-11-48-52
  9. Шевченко В.П., Нагаев И.Ю., Мясоедов Н.Ф. // Радиохимия. 2005. Т. 47. № 4. С. 368–373.
  10. Myasoedov N.F., Sidorov G.V., Kramerov V.N., Mi-shin V.I. // J. Label. Compd. Radiopharm. 1999. V. 42. № 9. P. 859–866. https://doi.org/10.1002/(SICI)1099-1344(199909) 42:9<859::AID-JLCR248>3.0.CO;2-5
  11. Шевченко В.П., Нагаев И.Ю., Мясоедов Н.Ф. Меченные тритием липофильные соединения. М.: Наука, 2003. 246 с.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
2.

Жүктеу (13KB)
3.

Жүктеу (28KB)
4.

Жүктеу (64KB)

© В.П. Шевченко, И.Ю. Нагаев, О.И. Куликова, Н.Ф. Мясоедов, 2023